|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 479.00 JPY | +0.21% |
|
-0.21% | -11.79% |
| 03-03 | IMPLANET Receives FDA Clearance for the Swingo Anterior Cervical Cage | CI |
| 11-14 | Arima informs on terms of JSS merger | RE |
Company Valuation: JSS Corporation
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 |
|---|---|
| Market Cap 1 | 1,695 |
| Change | - |
| Enterprise Value (EV) 1 | 3,138 |
| Change | - |
| P/E Ratio | 8.51x |
| PBR | 0.56x |
| PEG | - |
| Capitalization / Revenue | 0.2x |
| EV / Revenue | 0.37x |
| EV / EBITDA | 6.42x |
| EV / EBIT | 12.4x |
| EV / FCF | - |
| FCF Yield | - |
| Dividend per Share 2 | 17.5 |
| Rate of return | 4.16% |
| EPS 2 | 49.46 |
| Distribution rate | 35.4% |
| Net sales 1 | 8,381 |
| EBITDA 1 | 489 |
| EBIT 1 | 254 |
| Net income 1 | 192 |
| Net Debt 1 | 1,443 |
| Reference price 2 | 421.00 |
| Nbr of stocks (in thousands) | 4,026 |
| Announcement Date | 6/26/25 |
1JPY in Million2JPY
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 12.01M | |
| 18.64x | 3.5x | 11.43x | 1.77% | 10.61B | |
| 17.7x | 2.5x | 9.52x | - | 4.83B | |
| 172.04x | 1.07x | 9.25x | - | 1.74B | |
| 8.05x | 2.41x | 8.05x | 3.67% | 464M | |
| 21.74x | - | - | 0.7% | 342M | |
| 8.25x | - | - | 1.64% | 188M | |
| -3.9x | 0.73x | 4.26x | -.--% | 185M | |
| Average | 34.65x | 2.04x | 8.50x | 1.55% | 2.3B | |
| Weighted average by Cap. | 32.40x | 2.93x | 10.54x | 1.78% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 6074 Stock
- Valuation JSS Corporation
Select your edition
All financial news and data tailored to specific country editions
